Genmab A (GMAB) Amortizatization of Intangibles (2024 - 2026)
Genmab A (GMAB) reported Amortizatization of Intangibles of $13.0 million for Q1 2026, up 225.0% on a YoY basis from $4.0 million in Q1 2025, and up 18.18% quarter-over-quarter from $11.0 million in Q3 2025.
Genmab A (GMAB) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Genmab A has reported Amortizatization of Intangibles for 3 years, with the latest figure at $13.0 million in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles rose 225.0% year-over-year to $13.0 million; the trailing twelve-month figure through Mar 2026 stood at $35.0 million (up 105.88% YoY), and the FY2025 full-year result was $16.0 million, up 45.45% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $13.0 million, up from $11.0 million in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $13.0 million in Q1 2026, with the low at $2.0 million in Q1 2024.
- Historically, Amortizatization of Intangibles has averaged $6.9 million across 3 years, with a median of $7.0 million in 2024.
- Annual changes were most pronounced in 2025 — Amortizatization of Intangibles jumped 57.14% — and 2026, when it jumped 225.0%.
- Genmab A's Amortizatization of Intangibles stood at $7.0 million in 2024, then jumped by 57.14% to $11.0 million in 2025, then grew by 18.18% to $13.0 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $13.0 million (Q1 2026), $11.0 million (Q3 2025), and $7.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Genmab A | 48.34 Bn | 46.82 Bn | 831.00 Mn | 13.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.00 Mn |
| Mar 31, 2026 | 13.00 Mn |
| Sep 30, 2025 | 11.00 Mn |
| Sep 30, 2025 | 11.00 Mn |
| Jun 30, 2025 | 7.00 Mn |
| Jun 30, 2025 | 7.00 Mn |
| Mar 31, 2025 | 4.00 Mn |
| Mar 31, 2025 | 4.00 Mn |
| Sep 30, 2024 | 7.00 Mn |
| Sep 30, 2024 | 7.00 Mn |
| Jun 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 4.00 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Mar 31, 2024 | 2.00 Mn |